abstract |
Compounds of Formula (I): n n n n n n n n n n wherein R 1 -R 2 , W and Y are as described in the specification,n nand their salts and pro-drugs, are inhibitors of DGAT and are thereby useful in the treatment of, for example, obesity. Processes for preparing compounds of formula (I) are also described. |